INS and metabolic disease: These insights highlight miR-155’s complex role in metabolic disorders and it is suggested that its upregulation is linked with adipose tissue health and may counter insulin resistance in type 2 diabetes while enhancing insulin sensitivity in adipose tissue and muscle, aiding liver gluconeogenesis and protecting β-cells under stress [57].